PAUL LAURENCE E 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 21, 2012
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Purchase
Common Stock, no par value
2012-05-18$47.00/sh+5,000$235,000→ 42,397 total
Footnotes (1)
- [F1]This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.